Search filters

List of works by Maria H. Madeira

Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure

scientific article

Blockade of microglial adenosine A2A receptor impacts inflammatory mechanisms, reduces ARPE-19 cell dysfunction and prevents photoreceptor loss in vitro

scientific article

Blockade of microglial adenosine A2A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells

scientific article published on 22 January 2019

Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.

scientific article

Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases

scientific article

Elevated Pressure Changes the Purinergic System of Microglial Cells.

scientific article published on 24 January 2018

Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease.

scientific article

Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.

scientific article published on 31 January 2017

Intravitreal injection of adenosine A2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice

scientific article published on 20 November 2019

Keep an eye on adenosine: Its role in retinal inflammation

scientific article published on 26 February 2020

Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure–induced transient ischemic injury

scientific article published on 23 November 2015

Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes.

scientific article

Transient Downregulation of Melanopsin Expression After Retrograde Tracing or Optic Nerve Injury in Adult Rats.

scientific article

Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage

scientific article published on 5 October 2017